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Cell transplantation offers a potential new treatment for
stroke. Animal studies using models that produce is-
chemic damage in both the striatum and the frontal
cortex have shown beneficial effects when hNT cells
(postmitotic immature neurons) were transplanted into
the ischemic striatum. In this study, we investigated the
effect of hNT cells in a model of stroke in which the stria-
tum remains intact and damage is restricted to the cortex.
hNT cells were transplanted into the ischemic cortex 1
week after stroke induced by distal middle cerebral ar-
tery occlusion (dMCAo). The cells exhibited robust sur-
vival at 4 weeks posttransplant even at the lesion bor-
der. hNT cells did not migrate, but they did extend long
neurites into the surrounding parenchyma mainly through
the white matter. Neurite extension was predominantly
toward the lesion in ischemic animals but was bidirec-
tional in uninjured animals. Extension of neurites through
the cortex toward the lesion was also seen when there
was some surviving cortical tissue between the graft
and the infarct. Prolonged deficits were obtained in four
tests of sensory-motor function. hNT-transplanted ani-
mals showed a significant improvement in functional re-
covery on one motor test, but there was no effect on the
other three tests relative to control animals. Thus, de-
spite clear evidence of graft survival and neurite ex-
tension, the functional benefit of hNT cells after ische-
mia is not guaranteed. Functional benefit could depend
on other variables, such as infarct location, whether
the cells mature, the behavioral tests employed, reha-
bilitation training, or as yet unidentified factors.
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Cell transplantation offers therapeutic potential for
a number of CNS disorders, including Parkinson’s dis-
ease, Huntington’s disease, and stroke (Bjorklund and
Lindvall, 2000; Bjorklund et al., 2003; Isacson, 2003).
Repair of the brain after stroke is a formidable task, be-
cause the lesions are often large and involve cells of all
types (including neural and endothelial cells), resulting in
the loss of many complex synaptic connections. Despite
this, bone marrow cells, trophic factor-secreting kidney
cells, human neural stem cells, and immortalized cell
lines have been transplanted into the ischemic striatum
and, in many cases, have been shown to improve some
index of behavioral function in animal stroke models
(Borlongan et al., 1998c; Saporta et al., 1999; Nishino
and Borlongan, 2000; Chen et al., 2001; Veizovic et al.,
2001; Modo et al., 2002; Zhao et al., 2002; Savitz et al.,
2003).
A cell type that has shown potential in an animal
model of stroke and in clinical stroke trials is human
hNT cells (also known as NT2N cells or LBS neurons).
hNT cells are derived from embryonic carcinoma cells
from a human teratocarcinoma (NT2 cells; Andrews
et al., 1984). Treatment of NT2 cells with retinoic acid
results in terminal differentiation into immature neurons
(hNT cells), which maintain their neuronal phenotype
both in vitro and in vivo for over 1 year without revert-
ing to a neoplastic state (Pleasure and Lee, 1993; Troja-
nowski et al., 1993; Kleppner et al., 1995). These cells
have been reported to improve functional recovery
when transplanted into the ischemia-damaged striatum
of rats (Borlongan et al., 1998b,c; Saporta et al., 1999).
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hNT cells have also been used in clinical trials in patients
with basal ganglia stroke, with promising preliminary
results (Kondziolka et al., 2000, 2004; Meltzer et al.,
2001; Nelson et al., 2002).
Most studies of cell transplantation for stroke,
including those involving hNT cells, have assessed the
effect of cell transplantation into the striatum after focal
striatal ischemia (which can also damage the cortex to
varying degrees). However, many stroke patients have
damage restricted to the cortex with the striatum remain-
ing intact. There are relatively few reports on transplan-
tation into the ischemic cortex. Early studies of embry-
onic or fetal tissue transplanted into the lesioned cortex
reported improved functional outcomes (Kesslak et al.,
1986; Sinson et al., 1996). However, the effect of trans-
planting dissociated tissue or a renewable cell line (an
ethically and practically more viable option) into the is-
chemic cortex is not well documented (Hadani et al.,
1992). Furthermore, the requirements for repair of one
brain region may differ from those for other brain
regions. It remains to be seen whether transplanting cells
into the cortex will show the same potential for induc-
ing functional recovery as reported for striatal transplants
(Nishino and Borlongan, 2000; Savitz et al., 2002).
This study describes for the first time the utility of
transplanting hNT cells into the ischemic cortex. We
used a model of stroke produced by permanent occlu-
sion of the distal middle cerebral artery (dMCAo model),
a reproducible stroke model in which damage is re-
stricted to the frontal and parietal areas of the cortex and
may extend into the underlying white matter (Brint
et al., 1988; Markgraf et al., 1994; Roof et al., 2001).
We examined the ability of transplanted hNT neurons
to survive and integrate into the ischemic cortex and
determined the effect of these cells on functional out-
come by using a battery of sensorimotor behavior tests




All experimental protocols performed on animals were
approved by the Stanford University Administrative Panel on
Laboratory Animal Care. Age-matched, adult, male Sprague-
Dawley rats (320 6 10 g) were used. dMCAo was performed
with rats under isoflurane anesthesia as previously described
(Zhao et al., 2003). In brief, the distal portion of the MCA
was exposed through a small burr hole made between the left
eye and ear and cauterized and cut just above the rhinal fis-
sure. Both common carotid arteries were occluded for 1 hr.
Physiological parameters (EKG, core temperature, respiratory
rate) were monitored and recorded throughout the procedure.
Preparation of hNT Cells
hNT cells (LBS neurons) were freshly prepared at Lay-
ton Biosciences using GMP (good manufacturing practice)
and transplanted within 3 hr. In brief, cells were thawed and
resuspended in isolyte S buffer, viability was tested, and cell
density was adjusted to give a final concentration of 1 3 105
cells/ll. Cell viability was 53–67% prior to transplant and
exhibited at least 90% of this viability by the end of each
transplantation session.
Cortical Transplantation of hNT Cells
Stereotaxic surgery was performed with animals under
isoflurane anesthesia 7 days post-dMCAo. Rats were given
three 1.0-ll deposits of hNT cells (1 3 105 cells/ll, n ¼ 16;
or 1.0 ll of buffer vehicle, n ¼ 11) along the anterior-poste-
rior axis into the cortex at the following coordinates: 1) A-P:
þ1; M-L: –2.5; D-V: –2.8; 2) A-P: –0.26; M-L: –2.9; D-V:
–2.8; 3) A-P: –1.8; M-L: –2.4; D-V: –2.2 (Fig. 1). A micro-
infusion pump was used to control the speed of delivery at
0.5 ll/min. The needle was left in situ for 2 min postinjection
before being slowly removed. Cell-transplanted and control
rats were immunosuppressed by daily intraperitoneal injection
of cyclosporin A (CsA; 10 mg/kg) from post-dMCAo days
6–35.
Behavioral Testing
We used a battery of previously described behavior tests.
Forelimb usage for support and weight shifting during vertical
exploration was assessed (Schallert et al., 2000). Rats were
placed in a Plexiglas cylinder, and we counted the number of
times the rat reared and touched the cylinder in a weight-
bearing fashion with the left, right, or both forelimbs.
Approximately 20 of these limb-use movements were counted
per trial.
Somatosensory asymmetry was also assessed. Small adhe-
sive-backed stimuli (paper ‘‘dots’’) were placed on the distal-
radial part of each forelimb wrist, and the order of their re-
moval (left vs. right) was recorded (Schallert et al., 1982,
1983, 2000; Schallert and Whishaw, 1984). The size of the
dot on the preferred limb was reduced relative to the dot on
the nonpreferred limb until preference disappeared. The mag-
Fig. 1. Diagram of lesion position and transplant coordinates. hNT
cells were transplanted into three cortical sites (marked with an 3,
100,000 cells per site) along the A-P axis close to the lesion (gray
area). The lesion is restricted to the cortex and underlying white
matter; the striatum remains intact.
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nitude of the sensory deficit is indicated by the ratio of the
sizes of the contralateral and ipsilateral stimuli at which there
was no preference. The maximal ratio (i.e., 7.5) was scored if
rats always removed the dot from the unaffected limb regard-
less of the relative sizes of the dots.
Hind limb use was assessed using the ledged beam test
(Schallert et al., 2002). Rats were trained to walk along a nar-
row beam that had a safety ledge on either side. A fault was
recorded when a hind limb touched the ledge. The number
of faults per step was recorded for each limb. Five beam runs
were carried out per trial.
Turning bias after dMCAo was assessed by using the
postural asymmetry test (Schallert et al., 1982, 1983; Borlon-
gan et al., 1998c; Felt et al., 2002). Rats were held by the
base of the tail approximately 4 cm above the bench. The
direction toward which the rat turned its head (>108) was
recorded over 20 trials.
All rats were handled for 5 days and familiarized with
the adhesive dot removal and ledged beam walking tests for
3 days prior to testing. All tests were carried out before dMCAo
surgery on day 0 and on post-dMCAo days 2, 7 (before trans-
plant), 14, 21, 28, and 35 (Fig. 2).
Tissue Processing
Five weeks after dMCAo (4 weeks after transplantation)
rats were transcardially perfused with heparinized saline (0.5%)
and fixed with ice-cold paraformaldehyde (PFA; 3%). Brains
were left in the skull overnight in 3% PFA at 48C before
being transferred to 20% sucrose in PFA (3%). Five equidistant
sets of coronal sections (40 lm thick) were prepared on a
cryostat and stored in cryoprotectant at –208C until required.
Assessment of Cortical Lesion Size
Very little ischemic tissue remained 5 weeks after
dMCAo; in most rats, there was just an area of cortical tissue
loss. Therefore, we estimated lesion size (as a percentage of
the whole brain) by using the following formula: [(area of
contralateral hemisphere – area of remaining ipsilateral hemi-
sphere)/(area of contralateral hemisphere)] 3 100/2. The areas
of both the ipsilateral and the contralateral hemispheres were
measured on eight serial coronal sections per brain, 200 lm
apart, stained with hematoxylin and eosin (H&E). The area of
the infarct was averaged over these eight levels.
Immunohistochemical Staining
Standard immunohistochemical staining techniques were
used on free-floating sections. Sections were blocked in phos-
phate-buffered saline (PBS) containing 5% normal serum of
the species in which the secondary antibody was raised and
1% bovine seum albumin (BSA). All primary antibodies were
diluted in PBS containing 1% BSA and the same serum used
in the block (5%). Transplanted hNT cells were detected by
labeling with antibodies specific to human nuclei (Chemicon,
Temecula, CA), human-specific neurofilament light chain
(NF-70; Chemicon), human-specific neuron-specific enolase
(NSE; Novocastra Laboratories, Newcastle, United Kingdom),
or MOC-1 (Dako, Carpinteria, CA); MOC-1 antibody rec-
ognizes human neural cell adhesion molecule (N-CAM). In
brief, endogenous peroxidase activity was quenched with
H2O2 (0.3%), and sections were then blocked for 30 min and
incubated overnight at 48C with anti-human nuclei antibody
(1:30) or MOC-1 (1:100). Sections were washed and incu-
bated with biotinylated secondary antibody (Vector Laborato-
ries, Burlingame, CA) for 30 min, followed, after rinses, by a
30 min incubation with an avidin-biotin-peroxidase complex
(ABC, Vectastain Elite; Vector Laboratories) and visualized
with the chromogen Vector NovaRED or diaminobenzidine
(DAB; Vector Laboratories). The following phenotypic antibod-
ies were also used: guinea pig anti-GFAP (1:800; Advanced Im-
munochemical Inc., Long Beach, CA), rabbit anti-S100 (1:1,000;
Sigma, St. Louis, MO), and guinea pig anti-VGlut1 (1:5,000;
Chemicon) to detect vesicular glutamate transporters; rabbit
anti-GAD65/67 (1:600; Chemicon) to mark GABAergic neu-
rons; and goat anti-ChAT (1:500; Chemicon) to detect acetyl-
choline neurons. For fluorescent staining, the blocking and
primary antibody steps were as described above. The second-
ary antibodies used (1:1,000, 1 hr, room temperature) were
Alexafluor 488 anti-guinea pig and Alexafluor 546 anti-mouse
(Molecular Probes, Eugene, OR). Fluorescence-labeled sec-
tions were viewed with a confocal microscope. Z stacks were
obtained (optical section thickness of 1-lm; stack thickness
between 14 and 33 lm), and projection images of these z-
stacks are shown.
Unbiased Stereology and Cell Counting
The MOC-1 staining gave an indication of the number
of sections (per brain) that contained a bolus of cells as well as
the relative size of the bolus in each animal. From this infor-
mation, seven animals were chosen to determine hNT cell
survival accurately, including the animal with the fewest cells,
the one with the most cells, and representative animals in
between. The number of surviving transplanted hNT cells
was estimated by using unbiased computational stereology
(fractionator method, in Stereoinvestigator software; Micro-
BrightField, Brattleboro, VT). The number of surviving trans-
planted hNT cells was estimated from sections stained with
Fig. 2. Experimental design. Animals were trained 5 days prior to
stroke. Behavior tests were carried out on day 0 (before stroke), on
days 2 and 7 (after stroke, before transplantation), and then on days
14, 21, 28, and 35. All animals were given the immunosuppressant
cyclosporin A (CsA) daily.
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anti-human nuclei antibody and counted on every fifth sec-
tion (200 lm apart) through the three transplantation sites.
Transplanted hNT cell counts were corrected by using the
Abercrombie correction factor (nuclear diameter 5.17 lm,
determined from measurements of >20 hNT cell nuclei in
our stained sample).
Statistical Analysis
Statistical analyses were performed by using a repeated-
measures ANOVA. For the adhesive dot removal asymmetry
test, the ANOVA was performed by using a generalized esti-
mating equation with multinomal errors in SAS PROC
GENMOD. For all other tests, the ANOVA was performed
by using the generalized linear mixed model with autocorrela-
tion of the binomial errors over time, using the SAS glimmix
macro. Level of significance was defined a priori as P < 0.05.
Graphs were generated from mean and standard error meas-
urements.
RESULTS
Transplanted hNT Cells Survive Robustly in
Ischemic Cortex
Prominent grafts staining positively with an antibody
against human-specific N-CAM (Fig. 3A,B) were seen in
all animals at 4 weeks posttransplant, indicating robust sur-
vival of the transplanted hNT cells in the ischemic cortex
even at the lesion border. The cells also stained positively
for the neurofilament light chain NF-70 (Fig. 3C), and
for neuron-specific enolase (see Fig. 6C), confirming their
neuronal phenotype. Consistently with this, the grafts did
not stain with the astrocytic marker glial fibrillary acidic
protein (GFAP), although GFAP-positive host cells were
seen around the edge of the graft (Fig. 3E,F). The few
GFAP-positive cells within the graft are from the host,
insofar as they do not colocalize with human nuclei (sup-
plemental Fig. 1). A similar staining pattern was seen with
Fig. 3. hNT cell survival and neuronal phenotype. Four weeks post-
transplant, hNT cells were stained with an anti-human-specific N-
CAM (A,B,D) or for the human-specific light chain (NF70; C).
A–C show robust cell survival in the ischemic brain; D shows a graft
in an uninjured brain. Note: the cells seen in the striatum in D have
not migrated there but are from another graft site on the A-P
axis that hit the striatum. Most hNT cells do not stain for GFAP
(E,F); cells labeled with GFAP are green (E,F), cells stained with the
human nuclear marker are red (F). White arrow indicates the graft;
black arrow indicates the lesion. c, cortex; cc, corpus callosum; St,
striatum.
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the astrocytic marker S100b (data not shown). Despite
their neuronal phenotype, the grafts failed to stain with
antibodies specific for glutamatergic, cholinergic, and
GABAergic neurons (data not shown). Staining did occur
in endogenous rat cells, so failure to find colabeling of the
hNT cells was not due to failure of the immunohisto-
chemical reaction.
To quantitate hNT cell survival, brains were stained
with anti-human nuclei antibody so that individual cells
could be identified (Fig. 4A,B), and cells were counted
by using stereological methods. The proportion of trans-
planted hNT cells surviving in the ischemic cortex
ranged from 31% to 49% (mean survival 39.6% 6
2.2%), indicating that cell survival was very robust.
There was a trend for animals with larger lesions to have
less cell survival, but this was not statistically significant.
There was no correlation of cell survival with distance
of graft from the lesion (Table I). Despite extensive
survival, there was no significant difference in lesion
size between cell- and buffer-treated animals (11% 6 1%
vs. 9% 6 1%, respectively). Survival of hNT cells in
naı̈ve brains was equally robust, although the graft was
more elongated than the round bolus-type graft we typi-
cally found in the ischemic cortex (compare Fig. 3A,B
with D).
Transplanted hNT Cells Extend Processes
Preferentially Toward the Cortical Lesion
Transplanted hNT cells did not migrate; they sur-
vived where they were injected as fairly large cell boli
(see Fig. 3). Cells in some of the transplants extended
processes primarily along the white matter tracts of the
corpus callosum; this was observed in 46% (6 of 13) of
ischemic rats and 25% (1 of 4) of naı̈ve rats. The lack of
process extension from some grafts was mainly because
there was no white matter left along the lesion edge for
the processes to extend through or because the graft did
not penetrate the white matter. Processes extended for
up to 4.2 mm, and the mean length was 2.1 mm. In is-
chemic rats, processes extended predominantly through
the white matter in the direction of the cortical lesion
(Fig. 5A,B). Extension toward the midline was also seen,
but these processes were usually much shorter than the
lateral processes (Fig. 5A,B). Furthermore, in the two
brains in which some cortex remained between the graft
and the lesion, there was much greater process extension
from the lateral side of the graft, the side of the graft
nearer the lesion, than from the medial side of the graft
(Fig. 6A–E). Overall, this suggests a preference for proc-
esses to extend toward the area of damage. No colocali-
zation of these neurites and the synaptic marker synapto-
physin was found (data not shown). In the one naı̈ve
(no stroke) rat in which process extension was observed,
processes extended bidirectionally, with similar distances
in both directions (Fig. 6F).
Effect of Transplanted hNT Cells on
Behavioral Function
Each behavioral test showed that the cortical stroke
model, which damaged the frontal and parietal areas of
the cortex, including the motor and somatosensory over-
lap regions of the cortex, produced measurable func-
tional deficits with a bias toward greater use of the unaf-
Fig. 4. hNT cell survival in the ischemic brain. Four weeks posttransplant, hNT cells were stained
with a human nuclear marker (B shows a higher magnification of graft in A). White arrow indi-
cates the graft; black arrow indicates the lesion.
TABLE I. Comparison of Graft Survival With Lesion Size and









1 49 8.7 0
2 44 13.2 12
3 41 11.1 0
4 39 5.7 38
5 38 11.9 118
6 35 14.2 0
7 31 20.2 0
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fected limb and less use of the affected limb (Fig. 7).
There was no correlation between lesion size and the
magnitude of the behavioral deficit in any of the tests.
These deficits persisted for 5 weeks post-dMCAo, with
very little spontaneous recovery, except in the ledged
beam test, which showed recovery almost back to base-
line in both groups (Fig. 7C). There was greater recov-
ery in the ledged beam test in the cell-treated group
compared with the buffer group. This was significant
when taking into account total (i.e., L þ R) foot faults
(P ¼ 0.0037) and approached significance (P ¼ 0.082)
when just considering faults of the affected (i.e., R)
limb. There was no correlation between recovery in this
test and lesion size, extent of cell survival, proximity of
the graft to the lesion, or neurite extension of the trans-
planted cells. Despite surviving in high numbers and
extending long processes, transplanted hNT cells had no
significant effect, either positive or deleterious, on func-
tional behavior in the other tests performed. Although
there was no overall group effect on behavioral recov-
ery, some individual rats showed recovery both in the
buffer and in the cell groups. There was no correlation
of recovery in these rats with any of the parameters
mentioned above.
DISCUSSION
In contrast to the majority of studies in which vari-
ous cell types, including hNT cells, were transplanted
into the ischemia-damaged striatum, the present study
investigated the effect of transplanting hNT cells into
the ischemic cortex.
hNT Cell Survival
Extremely robust survival of the hNT cells was
seen in the cortex of both naı̈ve and stroke animals; in
ischemic rats 31–49% (mean survival 39.6% 6 2.2%) of
the initial transplanted cells survived. The majority of
these grafts were found at the edges of lesions, suggesting
that hNT cells can survive in ischemic tissue. This is in
stark contrast to other cell types, which do not survive
in such large numbers when transplanted too close to
the ischemic lesion (Sinson et al., 1996; Kelly et al.,
2004). This level of hNT survival is much greater than
that reported previously with these cells, which is
approximately 5–15% (Borlongan et al., 1998a; Saporta
et al., 1999, 2000). The difference may be due to the
fact that cells were transplanted into different brain
regions (i.e., cortex vs. striatum), and thus might have
Fig. 5. hNT cells extend long processes through the white matter. hNT cells were stained with an
anti-human-specific N-CAM. A,B: Representative images from two different ischemic brains
showing hNT neurite extension through the white matter predominantly in the direction of the
lesion. Insets show lower magnification of each image. Arrow indicates the lesion. c, cortex; cc,
corpus callosum; St, striatum.
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Fig. 6. hNT cells can extend processes through the cortex. hNT cells
were stained with an anti-human-specific N-CAM (A,B,F) or with
human-specific neuron-specific enolase (NSE; C–E). hNT cells can
extend neurites (arrowheads in B) through the cortex toward the lesion
(A–E). Boxed area in A is shown at higher magnification in B. C:
Low-magnification confocal image showing specific staining of the graft
with NSE. This section is taken from the same brain as that used in A.
D: Higher magnification of the medial edge of the graft (left box in
C). White dotted line indicates the edge of the graft. Red: NSE; blue:
DAPI. E: Higher magnification of the lateral edge of the graft (the edge
toward the lesion; right box in C). F: In uninjured animals, neurites
can extend bidirectionally through the white matter. Arrow indicates
the lesion. c, cortex; cc, corpus callosum; St, striatum.
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been exposed to environments that differentially influ-
enced survival. However, Saporta et al. (2000) reported
a similar extent of survival of cells transplanted into the
cortex and the striatum. Differences in cell handling and
preparation might also have contributed significantly to
this dramatic difference in cell survival.
hNT Cell Neurite Extension
Consistent with previous studies with hNT cells,
we saw no cell migration into the surrounding paren-
chyma. However, in many cases, the grafts extended
neurites into the surrounding host tissue, mainly through
the surrounding white matter, as reported in other stud-
ies (Trojanowski et al., 1993; Kleppner et al., 1995;
Muir et al., 1999; Philips et al., 1999; Lee et al., 2000),
although a clear boundary remained between the graft
and the host. There were a few grafts in both naı̈ve and
ischemic animals that showed little process extension; in
ischemic animals, these were usually in animals with lit-
tle remaining white matter. When process extension was
observed in naı̈ve animals, it was bidirectional (i.e.,
medial and lateral), whereas, in ischemic animals, long
process extension was primarily in the direction of the
lesion. In contrast, a previous study in which hNT cells
were transplanted into the ischemic striatum showed lit-
tle neurite outgrowth (Saporta et al., 1999). We also
observed processes extending through the ischemic cor-
tex toward the lesion in two animals in which some
intact cortex remained between the graft and the lesion.
It is tempting to speculate that the cells respond to envi-
ronmental cues from the lesion and target processes to-
ward the damage. An alternative explanation is that the
tissue is less compact near the lesion and that cell pro-
cesses simply followed a path of least resistance.
hNT Cell Differentation
Several studies have shown that hNT cells maintain
a neuronal phenotype in vivo and also express pheno-
typic markers appropriate for the host brain region.
These findings suggest that the cells respond to local en-
vironmental cues (Saporta et al., 2000). In our study, hNT
cells reacted with antibodies against a neural cell adhe-
sion molecule, a neurofilament marker, neuron-specific
enolase, but not with astrocytic markers; this is consistent
with the cells being neurons (Kleppner et al., 1995).
The cortex contains glutamatergic, cholinergic, and g-
aminobutyric acid (GABA)-ergic neurons, but we found
that none of the transplanted hNT cells colabeled with
Fig. 7. A–D: Effect of hNT cells on behavior. All behavior tests showed a functional deficit after
ischemia (compare day 0 vs. day 2). There was very little spontaneous recovery over time, except
in the ledged beam test (C). There was a significant difference in behavior only between cell- and
buffer-transplanted animals in the ledged beam test.
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markers for them (data not shown), suggesting perhaps
that the cells were not yet functionally mature at 4 weeks
posttransplantation. In keeping with this hypothesis, the
hNT cell neurites did not colocalize with synaptophysin
staining, which suggests that they were not yet forming
synapses. Other groups have also failed to find hNT cells
expressing mature phenotypic markers (Saporta et al.,
2000; Fricker-Gates et al., 2004). This is consistent with
the notion that human cells take longer to mature in the
rodent brain than rodent stem cells. Thus, longer time
points may be required to detect mature neurons, or
perhaps the brain environment after injury is just not
conducive to hNT cell maturation. The lack of cell mat-
uration may account for the inability of hNT cells to
enhance behavioral recovery in this study.
Effect of hNT Cells on Behavior
All four behavioral tests revealed significant deficits
after cortical stroke and, except in the ledged beam
test, these persisted throughout the 5-week period of
study. In previous studies in which MCAo damaged the
striatum (and hindlimb area of sensorimotor cortex),
spontaneous recovery in the ledged beam test did
not occur (Schallert et al., 2002). Roof et al. (2001)
reported a prolonged deficit in the cylinder test in their
cortical stroke model, but they found greater spontane-
ous recovery in the hangtail test. In our study, perform-
ance on the ledged beam test appeared to recover spon-
taneously almost back to baseline. Animals receiving cell
transplants showed a significant improvement in the
ledged beam test compared with the buffer group. How-
ever, there was no significant difference in behavior
between cell- and buffer-treated animals in the other
behavior tests. This suggests that improvement in motor
function was not a general phenomenon and may be de-
pendent on the behavioral test (Markgraf et al., 1994).
Other groups reported similar results; despite good cell
survival, they saw no improvement in functional behav-
ior either following transplantation of hNT cells into the
cortex after traumatic brain injury (Muir et al., 1999;
Philips et al., 1999) or after transplantation into the stria-
tum in a rat model of Huntington’s disease (Fricker-
Gates et al., 2004). Consistent with other reports, there
was no evidence that the cells had any deleterious effects
on behavior (Muir et al., 1999; Philips et al., 1999) de-
spite the grafts disrupting the laminar structure of the
cortex.
These data differ from the studies of Borlongan
et al. (1998b,c; Saporta et al., 1999) showing greater re-
covery of motor function after stroke within 1 month of
receiving transplants of hNT cells into the striatum. Sev-
eral differences between the studies may account for this
disparity. First, Borlongan et al. transplanted 1 month
postischemia and we transplanted 1 week postischemia.
It is well documented that the inflammatory response
(with respect to the magnitude of the response and the
cytokines present) following ischemia changes with time
(Barone and Feuerstein, 1999; Danton and Dietrich,
2003). Therefore, regardless of where cells are trans-
planted, the environment they are exposed to will differ
at 1 week vs. 4 weeks poststroke. Cytokines present at
1 week may interfere with the regenerative potential of
both the graft and the host cells. hNT cells have been
shown to express cytokine receptors (Hesselgesser et al.,
1997), so it is possible that hNT cells are influenced by
the inflammatory response, perhaps affecting their matu-
ration. Second, the stroke model used by Borlongan
et al. primarily damages the striatum, with some cortical
damage (Nishino et al., 1993). In our model, the stria-
tum remains intact, and it is likely that a greater extent
of the motor cortex is damaged compared with Borlon-
gan’s model, both factors that will influence motor func-
tion recovery (Markgraf et al., 1994). Third, they trans-
planted cells into the striatum, whereas we transplanted
into the cortex. Perhaps hNT cells behave differently in
the striatum compared with the cortex such that they
can facilitate recovery, or perhaps the damaged striatum
is more conducive to repair by transplanted cells than the
cortex. The literature on cortical transplants and functional
recovery is divided (Gates et al., 2000; Dobrossy and
Dunnett, 2001); some groups report that grafts of pri-
mary fetal tissue improved motor performance after cort-
ical infarcts (Kesslak et al., 1986; Sinson et al., 1996);
others report no amelioration of motor dysfunction
with such grafts (Dunnett et al., 1987; Sofroniew et al.,
1990; Kolb and Fantie, 1994). There is also evidence
that functional recovery after cortical transplants may
be dependent on the animals ‘‘learning to use’’ the
transplant (Dunnett et al., 1986; Mayer et al., 1992;
Dobrossy and Dunnett, 2001; Riolobos et al., 2001;
Kleim et al., 2003). Behavioral training may increase the
likelihood that the graft makes useful connections or
permit host tissue to allow more effective connections
(Jones and Schallert, 1994). Such training may be neces-
sary for the transplanted cells to have a therapeutic effect
in the cortex.
It is also possible that the outcomes of the behav-
ioral tests used to detect impairment and recovery are
susceptible to different interpretations. Borlongan and
colleagues used passive avoidance and postural asymme-
try tests. Passive avoidance is influenced by motor
impairments associated with basal ganglia dysfunction
and might have been exaggerated by grafts in the striatal
infarct model. If this is so, the animals might be more
likely to avoid the location in which they were previ-
ously shocked, not because of improved memory but
because they were less prone to move. In the postural
asymmetry test (elevated body swing test), the direction
of postural asymmetry differs in cortical vs. striatal mod-
els and between striatal models in which the intrinsic
striatal cells vs. nigrostriatal afferents are damaged. In the
cortical models, the direction of turning is contralateral,
because of a failure to show proprioceptive placing by
the affected limb (Whishaw et al., 1981; Kolb and
Whishaw, 1985). In contrast, the direction of turning is
ipsilateral following nigrostriatal afferent damage (due to
a postural asymmetry that overwhelms the placing asym-
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metry in this test) and can be contralateral or ipsilateral
in models of damage to the intrinsic neurons (Schallert
et al., 1982, 1983, 2000; Felt et al., 2002). Thus, a graft
conceivably could counteract an infarct-induced asym-
metry by impairing function rather than improving func-
tion. Of course, these are merely speculations, but they
suggest that it would be worth exploring the striatal
infarct model more thoroughly by using other behavioral
tests. It would be necessary to compare cortical and stria-
tal transplants using the same cells, behavior tests, and
timing of transplantation before truly conclusive state-
ments can be made about location-specific effects of the
transplanted cells.
CONCLUSIONS
In conclusion, this study has shown that hNT cells
transplanted into the ischemic cortex show extremely ro-
bust survival and extend long neurites through the white
matter and the cortex, primarily, but not exclusively, to-
ward the lesion. Despite this, recovery of function was
observed in only one of four behavioral tests. Whether
this lack of functional recovery is reflective of the loca-
tion (i.e., the cortex) or the timing of the transplant or
of the ability of the cells to mature is not clear. It might
simply be that the cortical lesion is too large and that
too many connections are severed to make repair feasi-
ble. It is evident that graft survival alone is not sufficient
to enhance functional recovery. Thus, if cell transplanta-
tion is to be used to repair cortical damage, several com-
plex issues concerning the location and severity of the
damage and the timing and location of the transplant
will have to be addressed.
ACKNOWLEDGMENTS
We thank Ray Sobel for help with microscopy,
Beth Hoyte for help with the figures, Hayden Rausch
for help with the stereology, Brandi Ormerod for help
with confocal microscopy, Unsal Kuscuoglu for help
with immunohistochemistry, and Dave Schaal for critical
reading of the manuscript. This work was supported
in part by National Institutes of Health, National Insti-
tute of Neurological Disorders and Stroke, grant P01
NS37520 (to G.K.S.).
REFERENCES
Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli
NC, Fogh J. 1984. Pluripotent embryonal carcinoma clones derived
from the human teratocarcinoma cell line Tera-2. Differentiation in
vivo and in vitro. Lab Invest 50:147–162.
Barone FC, Feuerstein GZ. 1999. Inflammatory mediators and stroke:
new opportunites for novel therapeutics. J Cereb Blood Flow Metab
19:819–834.
Bjorklund A, Lindvall O. 2000. Cell replacement therapies for central
nervous system disorders. Nat Neurosci 3:537–544.
Bjorklund A, Dunnett SB, Brundin P, Stoessl AJ, Freed CR, Breeze RE,
Levivier M, Peschanski M, Studer L, Barker R. 2003. Neural transplan-
tation for the treatment of Parkinson’s disease. Lancet Neurol 2:437–445.
Borlongan CV, Saporta S, Poulos SG, Othberg A, Sanberg PR. 1998a.
Viability and survival of hNT neurons determine degree of functional
recovery in grafted ischemic rats. Neuroreport 9:2837–2842.
Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR.
1998b. Cerebral ischemia and CNS transplantation: differential effects
of grafted fetal rat striatal cells and human neurons derived from a clo-
nal cell line. Neuroreport 9:3703–3709.
Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR.
1998c. Transplantation of cryopreserved human embryonal carcinoma-
derived neurons (NT2N cells) promotes functional recovery in ischemic
rats. Exp Neurol 149:310–321.
Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W. 1988. Focal
brain ischemia in the rat: methods for reproducible neocortical infarc-
tion using tandem occlusion of the distal middle cerebral and ipsilateral
common carotid arteries. J Cereb Blood Flow Metab 8:474–485.
Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M. 2001. Therapeutic
benefit of intracerebral transplantation of bone marrow stromal cells af-
ter cerebral ischemia in rats. J Neurol Sci 189:49–57.
Danton GH, Dietrich WD. 2003. Inflammatory mechanisms after ische-
mia and stroke. J Neuropathol Exp Neurol 62:127–136.
Dobrossy MD, Dunnett SB. 2001. The influence of environment and ex-
perience on neural grafts. Nat Rev Neurosci 2:871–879.
Dunnett SB, Whishaw IQ, Bunch ST, Fine A. 1986. Acetylcholine-rich
neuronal grafts in the forebrain of rats: effects of environmental enrich-
ment, neonatal noradrenaline depletion, host transplantation site and re-
gional source of embryonic donor cells on graft size and acetylcholines-
terase-positive fibre outgrowth. Brain Res 378:357–373.
Dunnett SB, Ryan CN, Levin PD, Reynolds M, Bunch ST. 1987. Func-
tional consequences of embryonic neocortex transplanted to rats with
prefrontal cortex lesions. Behav Neurosci 101:489–503.
Felt BT, Schallert T, Shao J, Liu Y, Li X, Barks JD. 2002. Early appear-
ance of functional deficits after neonatal excitotoxic and hypoxic-ische-
mic injury: fragile recovery after development and role of the NMDA
receptor. Dev Neurosci 24:418–425.
Fricker-Gates RA, Muir JA, Dunnett SB. 2004. Transplanted hNT cells
(‘‘LBS neurons’’) in a rat model of Huntington’s disease: good survival,
incomplete differentiation, and limited functional recovery. Cell Trans-
plant 13:123–136.
Gates MA, Fricker-Gates RA, Macklis JD. 2000. Reconstruction of cort-
ical circuitry. Prog Brain Res 127:115–156.
Hadani M, Freeman T, Munsiff A, Young W, Flamm E. 1992. Fetal
cortical cells survive in focal cerebral infarct after permanent occlusion
of the middle cerebral artery in adult rats. J Neurotrauma 9:107–112.
Hesselgesser J, Halks-Miller M, DelVecchio V, Peiper SC, Hoxie J, Kol-
son DL, Taub D, Horuk R. 1997. CD4-independent association
between HIV-1 gp120 and CXCR4: functional chemokine receptors
are expressed in human neurons. Curr Biol 7:112–121.
Isacson O. 2003. The production and use of cells as therapeutic agents in
neurodegenerative diseases. Lancet Neurol 2:417–424.
Jones TA, Schallert T. 1994. Use-dependent growth of pyramidal neu-
rons after neocortical damage. J Neurosci 14:2140–2152.
Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, Masel J, Yenari
MA, Weissman IL, Uchida N, Palmer T, Steinberg GK. 2004. Trans-
planted human fetal neural stem cells survive, migrate, and differentiate in
ischemic rat cerebral cortex. Proc Natl Acad Sci U S A 101:11839–11844.
Kesslak JP, Brown L, Steichen C, Cotman CW. 1986. Adult and embry-
onic frontal cortex transplants after frontal cortex ablation enhance re-
covery on a reinforced alternation task. Exp Neurol 94:615–626.
Kleim JA, Jones TA, Schallert T. 2003. Motor enrichment and the induction
of plasticity before or after brain injury. Neurochem Res 28:1757–1769.
Kleppner SR, Robinson KA, Trojanowski JQ, Lee VM. 1995. Trans-
planted human neurons derived from a teratocarcinoma cell line (NTera-2)
mature, integrate, and survive for over 1 year in the nude mouse brain.
J Comp Neurol 357:618–632.
Kolb B, Fantie B. 1994. Cortical graft function in adult and neonatal rats.
In: Dunnett SB, Bjorklund A, editors. Functional neural transplantation.
New York: Raven. p 415–436.
hNt Cell Transplant Into Ischemic Cortex 1013
Journal of Neuroscience Research DOI 10.1002/jnr
Kolb B, Whishaw IQ. 1985. An observer’s view of locomotor asymmetry
in the rat. Neurobehav Toxicol Teratol 7:71–78.
Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR,
Gebel J, Jannetta P, DeCesare S, Elder EM, McGrogan M, Reitman
MA. 2000. Transplantation of cultured human neuronal cells for
patients with stroke. Neurology 55:565–569.
Kondziolka D, Steinberg GK, Wechsler L, Meltzer C, Elder E, Gebel J,
DeCesare S, Jovin T, Zafonte R, Leibrowitz J, Flickinger JC, Tong D,
Marks M, Jamieson C, Luu D, Bell-Stephens T, Teraoka J. 2004.
Neurotransplantation for patients with subcortical motor stroke: a phase 2
randomized trial. J Neurosurg J Neurosurg (submitted).
Lee VM, Hartley RS, Trojanowski JQ. 2000. Neurobiology of human
neurons (NT2N) grafted into mouse spinal cord: implications for
improving therapy of spinal cord injury. Prog Brain Res 128:299–
307.
Markgraf CG, Green EJ, Watson B, McCabe PM, Schneiderman N,
Dietrich WD, Ginsberg MD. 1994. Recovery of sensorimotor function
after distal middle cerebral artery photothrombotic occlusion in rats.
Stroke 25:153–159.
Mayer E, Brown VJ, Dunnett SB, Robbins TW. 1992. Striatal graft-asso-
ciated recovery of a lesion-induced performance deficit in the rat
requires learning to use the transplant. Eur J Neurosci 4:119–126.
Meltzer CC, Kondziolka D, Villemagne VL, Wechsler L, Goldstein S,
Thulborn KR, Gebel J, Elder EM, DeCesare S, Jacobs A. 2001. Serial
[18F]fluorodeoxyglucose positron emission tomography after human
neuronal implantation for stroke. Neurosurgery 49:586–591; discussion
591–582.
Modo M, Stroemer RP, Tang E, Patel S, Hodges H. 2002. Effects of
implantation site of stem cell grafts on behavioral recovery from stroke
damage. Stroke 33:2270–2278.
Muir JK, Raghupathi R, Saatman KE, Wilson CA, Lee VM, Trojanow-
ski JQ, Philips MF, McIntosh TK. 1999. Terminally differentiated
human neurons survive and integrate following transplantation into the
traumatically injured rat brain. J Neurotrauma 16:403–414.
Nelson PT, Kondziolka D, Wechsler L, Goldstein S, Gebel J, DeCesare S,
Elder EM, Zhang PJ, Jacobs A, McGrogan M, Lee VM, Trojanowski JQ.
2002. Clonal human (hNT) neuron grafts for stroke therapy: neuropa-
thology in a patient 27 months after implantation. Am J Pathol 160:
1201–1206.
Nishino H, Borlongan CV. 2000. Restoration of function by neural
transplantation in the ischemic brain. Prog Brain Res 127:461–476.
Nishino H, Koide K, Aihara N, Kumazaki M, Sakurai T, Nagai H.
1993. Striatal grafts in the ischemic striatum improve pallidal GABA
release and passive avoidance. Brain Res Bull 32:517–520.
Philips MF, Muir JK, Saatman KE, Raghupathi R, Lee VM, Trojanowski
JQ, McIntosh TK. 1999. Survival and integration of transplanted post-
mitotic human neurons following experimental brain injury in immuno-
competent rats. J Neurosurg 90:116–124.
Pleasure SJ, Lee VM. 1993. NTera 2 cells: a human cell line which dis-
plays characteristics expected of a human committed neuronal progeni-
tor cell. J Neurosci Res 35:585–602.
Riolobos AS, Heredia M, de la Fuente JA, Criado JM, Yajeya J, Campos J,
Santacana M. 2001. Functional recovery of skilled forelimb use in rats
obliged to use the impaired limb after grafting of the frontal cortex lesion
with homotopic fetal cortex. Neurobiol Learn Mem 75:274–292.
Roof RL, Schielke GP, Ren X, Hall ED. 2001. A comparison of long-
term functional outcome after 2 middle cerebral artery occlusion mod-
els in rats. Stroke 32:2648–2657.
Saporta S, Borlongan CV, Sanberg PR. 1999. Neural transplantation of
human neuroteratocarcinoma (hNT) neurons into ischemic rats. A quanti-
tative dose-response analysis of cell survival and behavioral recovery.
Neuroscience 91:519–525.
Saporta S, Willing AE, Colina LO, Zigova T, Milliken M, Daadi MM,
Sanberg PR. 2000. In vitro and in vivo characterization of hNT neu-
ron neurotransmitter phenotypes. Brain Res Bull 53:263–268.
Savitz SI, Rosenbaum DM, Dinsmore JH, Weschler LR, Caplan LR.
2002. Cell transplantation for stroke. Ann Neurol 53:266–275.
Savitz SI, Malhotra S, Gupta G, Rosenbaum DM. 2003. Cell transplants
offer promise for stroke recovery. J Cardiovascular Nursing 18:57–61.
Schallert T, Whishaw IQ. 1984. Bilateral cutaneous stimulation of the
somatosensory system in hemidecorticate rats. Behav Neurosci 98:518–
540.
Schallert T, Upchurch M, Lobaugh N, Farrar SB, Spirduso WW, Gilliam
P, Vaughn D, Wilcox RE. 1982. Tactile extinction: distinguishing
between sensorimotor and motor asymmetries in rats with unilateral ni-
grostriatal damage. Pharmacol Biochem Behav 16:455–462.
Schallert T, Upchurch M, Wilcox RE, Vaughn DM. 1983. Posture-
independent sensorimotor analysis of inter-hemispheric receptor asym-
metries in neostriatum. Pharmacol Biochem Behav 18:753–759.
Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST. 2000. CNS
plasticity and assessment of forelimb sensorimotor outcome in unilateral
rat models of stroke, cortical ablation, parkinsonism and spinal cord in-
jury. Neuropharmacology 39:777–787.
Schallert T, Woodlee MT, Fleming SM. 2002. Disentangling multiple types
of recovery from brain injury. In: Klumpp JK, editor. Pharmacology of
cerebral ischemia. Stuttgart: Medpharm Scientific Publishers. p 201–216.
Sinson G, Voddi M, McIntosh TK. 1996. Combined fetal neural transplan-
tation and nerve growth factor infusion: effects on neurological outcome
following fluid-percussion brain injury in the rat. J Neurosurg 84:655–662.
Sofroniew MV, Dunnett SB, Isacson O. 1990. Remodelling of intrinsic
and afferent systems in neocortex with cortical transplants. Prog Brain
Res 82:313–320.
Trojanowski JQ, Mantione JR, Lee JH, Seid DP, You T, Inge LJ, Lee
VM. 1993. Neurons derived from a human teratocarcinoma cell line
establish molecular and structural polarity following transplantation into
the rodent brain. Exp Neurol 122:283–294.
Veizovic T, Beech JS, Stroemer RP, Watson WP, Hodges H. 2001. Re-
solution of stroke deficits following contralateral grafts of conditionally
immortal neuroepithelial stem cells. Stroke 32:1012–1019.
Whishaw IQ, Schallert T, Kolb B. 1981. An analysis of feeding and sen-
sorimotor abilities of rats after decortication. J Comp Physiol Psychol
95:85–103.
Zhao H, Yenari MA, Cheng D, Sapolsky RM, Steinberg GK. 2003.
Bcl-2 overexpression protects against neuron loss within the ischemic
margin following experimental stroke and inhibits cytochrome c trans-
location and caspase-3 activity. J Neurochem 85:1026–1036.
Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC.
2002. Human bone marrow stem cells exhibit neural phenotypes and
ameliorate neurological deficits after grafting into the ischemic brain of
rats. Exp Neurol 174:11–20.
1014 Bliss et al.
Journal of Neuroscience Research DOI 10.1002/jnr
